Galderma Group AG (SWX:GALD)
Switzerland · Delayed Price · Currency is CHF 173.00
-5.55 (-3.11%)
Aug 14, 2026, 5:31 PM CET
Galderma Group AG Market Cap
Galderma Group AG has a market cap or net worth of 40.34 billion as of August 14, 2026. Its market cap has increased by 30.11% in one year.
Market Cap
40.34B
Enterprise Value
41.86B
Revenue
4.79B
Ranking
n/a
PE Ratio
58.62
Stock Price
173.00
ChartMarket Cap Chart
Since March 22, 2024, Galderma Group AG's market cap has increased from 15.20B to 40.34B, an increase of 165.33%. That is a compound annual growth rate of 50.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 40.34B | 4.83% |
| Dec 30, 2025 | 38.48B | 60.96% |
| Dec 30, 2024 | 23.91B | 57.25% |
| Mar 22, 2024 | 15.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 289.26B |
| Novartis AG | 232.72B |
| Lonza Group AG | 40.01B |
| Sandoz Group AG | 31.90B |
| Alcon | 28.75B |
| Straumann Holding AG | 16.27B |
| Sonova Holding AG | 14.16B |
| Bachem Holding AG | 5.63B |